Healthcare - Sector
CORT is currently covered by 5 analysts with an average price target of $119.8. This is a potential upside of $56.18 (88.31%) from yesterday's end of day stock price of $63.62.
Our record on Corcept Therapeutics covers 15 analysts since 2008; 5 cover it today. Of the 129 price targets those analysts set on CORT, 98 were reached (76%). The highest performance score on Corcept Therapeutics belongs to Joon Lee of Truist: 14.67, with 10 of 13 targets met in 168 days on average. The latest calls: David Amsellem of Piper Sandler raised the target to $173 from $165 with a Buy rating on 4 Nov 2026; Swayampakula Ramakanth of H.C. Wainwright kept the target at $165 with a Buy rating on 18 Sep 2026; Edward Nash of Canaccord raised the target to $161 from $135 with a Buy rating on 30 Jul 2026. Figures as of 18 Nov 2026.
Corcept Therapeutics's activity chart (see below) currently has 139 price targets and 129 ratings on display. The stock rating distribution of CORT is 84.62% BUY, 7.69% HOLD and 7.69% SELL.
Analysts' price targets on this stock were met 75.76% of the time, taking 241.92 days on average.
Highest price target for CORT is $173, Lowest price target is $50, average price target is $119.8.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 04-Nov-2026. First documented stock forecast 11-Mar-2015.
Currently out of the existing stock ratings of CORT, 22 are a BUY (84.62%), 2 are a HOLD (7.69%), 2 are a SELL (7.69%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Apr-2023
$173
$109.38 (171.93%)
$165
18 days ago
(04-Nov-2026)
11/15 (73.33%)
$93.78 (118.38%)
109
Buy Since 06-Sep-2019
$165
$101.38 (159.35%)
$165
2 months 4 days ago
(18-Sep-2026)
29/38 (76.32%)
$54.71 (49.61%)
202
Buy Since 27-Jun-2022
$161
$97.38 (153.07%)
$135
3 months 23 days ago
(30-Jul-2026)
14/24 (58.33%)
$42.68 (36.07%)
233
Hold Since 27-Jul-2026
$50
$-13.62 (-21.41%)
3 months 26 days ago
(27-Jul-2026)
0/2 (0%)
$-41.12 (-45.13%)
Buy Since 03-Jan-2024
$50
$-13.62 (-21.41%)
$135
10 months 22 days ago
(31-Dec-2025)
10/13 (76.92%)
$15.2 (43.68%)
168
What is CORT (Corcept Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CORT (Corcept Therapeutics)?
Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?
Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?
Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?